Sea Crest Wealth Management, LLC Amgen Inc Transaction History

Sea Crest Wealth Management, LLC

$852 Million
Q1 2025

A detailed history of Sea Crest Wealth Management, LLC transactions in Amgen Inc stock. As of the latest transaction made, Sea Crest Wealth Management, LLC holds 15,861 shares of AMGN stock, worth $4.57 Million. This represents 0.58% of its overall portfolio holdings.

Number of Shares

15,861

Previous 16,298 2.68%

Holding current value

$4.57 Million

Previous $4.25 Million 16.34%

% of portfolio

0.58%

Previous 0.46%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 11, 2025	SELL	$258.59 - $327.36 $113,003 - $143,056	-437 Reduced 2.68%	15,861 $4.94 Million
Q4 2024 Jan 14, 2025	SELL	$258.78 - $328.31 $798,336 - $1.01 Million	-3,085 Reduced 15.92%	16,298 $4.25 Million
Q3 2024 Oct 16, 2024	BUY	$309.38 - $337.38 $35,269 - $38,461	114 Added 0.59%	19,383 $6.25 Million
Q2 2024 Jul 19, 2024	BUY	$262.75 - $319.31 $682,624 - $829,567	2,598 Added 15.58%	19,269 $6.02 Million
Q1 2024 Apr 18, 2024	SELL	$268.87 - $324.56 $57,000 - $68,806	-212 Reduced 1.26%	16,671 $4.74 Million
Q4 2023 Jan 18, 2024	SELL	$255.7 - $288.46 $22,501 - $25,384	-88 Reduced 0.52%	16,883 $4.86 Million
Q3 2023 Oct 12, 2023	SELL	$218.65 - $271.46 $61,659 - $76,551	-282 Reduced 1.63%	16,971 $4.56 Million
Q2 2023 Jul 14, 2023	SELL	$214.27 - $253.37 $110,349 - $130,485	-515 Reduced 2.9%	17,253 $3.83 Million
Q1 2023 May 11, 2023	BUY	$225.79 - $275.2 $55,544 - $67,699	246 Added 1.4%	17,768 $4.3 Million
Q4 2022 Feb 14, 2023	SELL	$229.03 - $291.01 $14,199 - $18,042	-62 Reduced 0.35%	17,522 $4.6 Million
Q3 2022 Nov 14, 2022	BUY	$224.46 - $253.15 $80,132 - $90,374	357 Added 2.07%	17,584 $3.96 Million
Q2 2022 Aug 09, 2022	SELL	$230.71 - $256.74 $16,149 - $17,971	-70 Reduced 0.4%	17,227 $4.19 Million
Q1 2022 May 16, 2022	BUY	$219.27 - $242.57 $26,970 - $29,836	123 Added 0.72%	17,297 $4.18 Million
Q4 2021 Feb 11, 2022	SELL	$198.88 - $227.6 $810,436 - $927,470	-4,075 Reduced 19.18%	17,174 $3.86 Million
Q3 2021 Nov 16, 2021	SELL	$212.27 - $248.7 $70,685 - $82,817	-333 Reduced 1.54%	21,249 $4.52 Million
Q2 2021 Aug 12, 2021	BUY	$233.58 - $259.14 $39,241 - $43,535	168 Added 0.78%	21,582 $5.26 Million
Q1 2021 May 17, 2021	BUY	$221.91 - $258.6 $266,735 - $310,837	1,202 Added 5.95%	21,414 $5.33 Million
Q4 2020 Feb 09, 2021	BUY	$216.38 - $257.67 $54,744 - $65,190	253 Added 1.27%	20,212 $4.65 Million
Q3 2020 Nov 12, 2020	BUY	$234.65 - $260.95 $43,879 - $48,797	187 Added 0.95%	19,959 $5.07 Million
Q2 2020 Jul 27, 2020	BUY	$197.81 - $242.74 $30,264 - $37,139	153 Added 0.78%	19,772 $4.66 Million
Q1 2020 May 13, 2020	BUY	$182.24 - $241.7 $98,774 - $131,001	542 Added 2.84%	19,619 $3.98 Million
Q4 2019 Jan 22, 2020	BUY	$189.21 - $243.2 $50,897 - $65,420	269 Added 1.43%	19,077 $4.6 Million
Q3 2019 Oct 15, 2019	BUY	$174.11 - $208.62 $1.69 Million - $2.03 Million	9,729 Added 107.16%	18,808 $3.64 Million
Q2 2019 Jul 19, 2019	BUY	$166.7 - $195.41 $50,843 - $59,600	305 Added 3.48%	9,079 $1.67 Million
Q1 2019 May 10, 2019	BUY	$180.87 - $203.88 $41,057 - $46,280	227 Added 2.66%	8,774 $1.67 Million
Q4 2018 Feb 13, 2019	SELL	$178.4 - $208.25 $84,383 - $98,502	-473 Reduced 5.24%	8,547 $1.66 Million
Q3 2018 Nov 14, 2018	BUY	$185.29 - $208.89 $27,237 - $30,706	147 Added 1.66%	9,020 $1.87 Million
Q2 2018 Aug 03, 2018	SELL	$166.05 - $186.51 $41,678 - $46,814	-251 Reduced 2.75%	8,873 $1.64 Million
Q1 2018 Apr 20, 2018	SELL	$169.43 - $198.0 $17,959 - $20,988	-106 Reduced 1.15%	9,124 $1.56 Million
Q4 2017 Feb 02, 2018	BUY	$168.79 - $188.59 $1.56 Million - $1.74 Million	9,230	9,230 $1.61 Million

Others Institutions Holding AMGN

# of Institutions

3,309

Shares Held

429M

Call Options Held

8.06M

Put Options Held

7.7M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $154B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sea Crest Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sea Crest Wealth Management, LLC with notifications on news.

Account

Sea Crest Wealth Management, LLC Amgen Inc Transaction History